Literature DB >> 26372364

Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners.

Kristine A Donovan1, Lauren M Walker2,3, Richard J Wassersug4,5, Lora M A Thompson1, John W Robinson2,3,6.   

Abstract

The clinical benefits of androgen-deprivation therapy (ADT) for men with prostate cancer (PC) have been well documented and include living free from the symptoms of metastases for longer periods and improved quality of life. However, ADT comes with a host of its own serious side effects. There is considerable evidence of the adverse cardiovascular, metabolic, and musculoskeletal effects of ADT. Far less has been written about the psychological effects of ADT. This review highlights several adverse psychological effects of ADT. The authors provide evidence for the effect of ADT on men's sexual function, their partner, and their sexual relationship. Evidence of increased emotional lability and depressed mood in men who receive ADT is also presented, and the risk of depression in the patient's partner is discussed. The evidence for adverse cognitive effects with ADT is still emerging but suggests that ADT is associated with impairment in multiple cognitive domains. Finally, the available literature is reviewed on interventions to mitigate the psychological effects of ADT. Across the array of adverse effects, physical exercise appears to have the greatest potential to address the psychological effects of ADT both in men who are receiving ADT and in their partners.
© 2015 American Cancer Society.

Entities:  

Keywords:  androgen-deprivation therapy; cognition; depression; prostate cancer; sexual function

Mesh:

Substances:

Year:  2015        PMID: 26372364     DOI: 10.1002/cncr.29672

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  32 in total

1.  Lack of AR in LepRb Cells Disrupts Ambulatory Activity and Neuroendocrine Axes in a Sex-Specific Manner in Mice.

Authors:  Alexandra L Cara; Martin G Myers; Carol F Elias
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

2.  Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study.

Authors:  Lisa M Wu; Molly L Tanenbaum; Marcel P J M Dijkers; Ali Amidi; Simon J Hall; Frank J Penedo; Michael A Diefenbach
Journal:  Soc Sci Med       Date:  2016-03-17       Impact factor: 4.634

3.  Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.

Authors:  Kristine A Donovan; Brian D Gonzalez; Ashley M Nelson; Mayer N Fishman; Babu Zachariah; Paul B Jacobsen
Journal:  Psychooncology       Date:  2017-06-27       Impact factor: 3.894

4.  Depression, Anxiety, and Patterns of Mental Health Care Among Men With Prostate Cancer Receiving Androgen Deprivation Therapy.

Authors:  Phoebe A Tsao; Ryan D Ross; Amy S B Bohnert; Bhramar Mukherjee; Megan E V Caram
Journal:  Oncologist       Date:  2022-04-05

5.  Mood, sexuality, and relational intimacy after starting androgen deprivation therapy: implications for couples.

Authors:  Lauren M Walker; Pablo Santos-Iglesias; John Robinson
Journal:  Support Care Cancer       Date:  2018-05-18       Impact factor: 3.603

6.  Improvement in Therapeutic Efficacy and Reduction in Cellular Toxicity: Introduction of a Novel Anti-PSMA-Conjugated Hybrid Antiandrogen Nanoparticle.

Authors:  Chellappagounder Thangavel; Maryna Perepelyuk; Ettickan Boopathi; Yi Liu; Steven Polischak; Deepak A Deshpande; Khadija Rafiq; Adam P Dicker; Karen E Knudsen; Sunday A Shoyele; Robert B Den
Journal:  Mol Pharm       Date:  2018-04-04       Impact factor: 4.939

Review 7.  Androgen Deprivation Therapy and Cognitive Function in Prostate Cancer.

Authors:  Jonathan Kluger; Alicia Roy; Herta H Chao
Journal:  Curr Oncol Rep       Date:  2020-02-11       Impact factor: 5.075

Review 8.  Cognitive and Psychological Impacts of Different Treatment Options for Prostate Cancer: A Critical Analysis.

Authors:  Konstantina G Yiannopoulou; Aikaterini I Anastasiou; Konstantinos Kontoangelos; Charalambos Papageorgiou; Ioannis P Anastasiou
Journal:  Curr Urol       Date:  2020-12-18

9.  Feasibility of an intervention for men on androgen deprivation therapy: A research protocol.

Authors:  Alana Manson; Jamie Myers; Sandra Billinger; Jaimie Ward; William Parker; Jill Hamilton-Reeves; Carrie Michel; Sally L Maliski
Journal:  Res Nurs Health       Date:  2019-08-07       Impact factor: 2.228

10.  Antidepressant prescriptions and associated factors in men with prostate cancer and their female partners.

Authors:  Tim J Hartung; Ida Rask Moustsen; Signe Benzon Larsen; Elisabeth A Wreford Andersen; Nis P Suppli; Christoffer Johansen; Anne Tjønneland; Anne S Friberg; Susanne K Kjær; Klaus Brasso; Lars V Kessing; Anja Mehnert; Susanne Oksbjerg Dalton
Journal:  J Cancer Surviv       Date:  2020-10-13       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.